Younossi, Zobair

Up a level
Export as [feed] RSS
Group by: Item Type | No Grouping
Number of items: 6.

Abeysekera, Kushala W M; Valenti, Luca; Younossi, Zobair; Dillon, John F; Allen, Alina M; Nourredin, Mazen; Rinella, Mary E; Tacke, Frank; Francque, Sven; Ginès, Pere; Thiele, Maja; Newsome, Philip N; Guha, Indra Neil; Eslam, Mohammed; Schattenberg, Jörn M; Alqahtani, Saleh A; Arrese, Marco; Berzigotti, Annalisa; Holleboom, Adriaan G; Caussy, Cyrielle; ... (2024). Implementation of a liver health check in people with type 2 diabetes. The lancet. Gastroenterology & hepatology, 9(1), pp. 83-91. Elsevier 10.1016/S2468-1253(23)00270-4

Rinella, Mary E; Lazarus, Jeffrey V; Ratziu, Vlad; Francque, Sven M; Sanyal, Arun J; Kanwal, Fasiha; Romero, Diana; Abdelmalek, Manal F; Anstee, Quentin M; Arab, Juan Pablo; Arrese, Marco; Bataller, Ramon; Beuers, Ulrich; Boursier, Jerome; Bugianesi, Elisabetta; Byrne, Christopher D; Castro Narro, Graciela E; Chowdhury, Abhijit; Cortez-Pinto, Helena; Cryer, Donna R; ... (2023). A multisociety Delphi consensus statement on new fatty liver disease nomenclature. Hepatology, 78(6), pp. 1966-1986. Wiley 10.1097/HEP.0000000000000520

Rinella, Mary; Dufour, Jean-François; Anstee, Quentin M; Goodman, Zachary; Younossi, Zobair; Harrison, Stephen A; Loomba, Rohit; Sanyal, Arun J; Bonacci, Martin; Trylesinski, Aldo; Natha, Macky; Shringarpure, Reshma; Granston, Tanya; Venugopal, Aditya; Ratziu, Vlad (2022). Non-invasive evaluation of response to obeticholic acid in patients with NASH: Results from the REGENERATE study. Journal of hepatology, 76(3), pp. 536-548. Elsevier 10.1016/j.jhep.2021.10.029

Sanyal, Arun J; Harrison, Stephen A; Ratziu, Vlad; Abdelmalek, Manal F; Diehl, Anna Mae; Caldwell, Stephen; Shiffman, Mitchell L; Aguilar Schall, Raul; Jia, Catherine; McColgan, Bryan; Djedjos, C Stephen; McHutchison, John G; Subramanian, G Mani; Myers, Robert P; Younossi, Zobair; Muir, Andrew J; Afdhal, Nezam H; Bosch, Jaime; Goodman, Zachary (2019). The Natural History of Advanced Fibrosis Due to Nonalcoholic Steatohepatitis: Data From the Simtuzumab Trials. Hepatology, 70(6), pp. 1913-1927. Wiley 10.1002/hep.30664

Younossi, Zobair; Stepanova, Maria; Sanyal, Arun J; Harrison, Stephen A; Ratziu, Vlad; Abdelmalek, Manal F; Diehl, Anna Mae; Caldwell, Stephen; Shiffman, Mitchell L; Schall, Raul Aguilar; McColgan, Bryan; Subramanian, G Mani; Myers, Robert P; Muir, Andrew; Afdhal, Nezam H; Bosch, Jaime; Goodman, Zachary (2018). The conundrum of cryptogenic cirrhosis: Adverse outcomes without treatment options. Journal of hepatology, 69(6), pp. 1365-1370. Elsevier 10.1016/j.jhep.2018.08.013

Harrison, Stephen A; Abdelmalek, Manal F; Caldwell, Stephen; Shiffman, Mitchell L; Diehl, Anna Mae; Ghalib, Reem; Lawitz, Eric J; Rockey, Don C; Schall, Raul Aguilar; Jia, Catherine; McColgan, Bryan J; McHutchison, John G; Subramanian, G Mani; Myers, Robert P; Younossi, Zobair; Ratziu, Vlad; Muir, Andrew J; Afdhal, Nezam H; Goodman, Zachary; Bosch, Jaime; ... (2018). Simtuzumab Is Ineffective for Patients With Bridging Fibrosis or Compensated Cirrhosis Caused by Nonalcoholic Steatohepatitis. Gastroenterology, 155(4), pp. 1140-1153. Elsevier 10.1053/j.gastro.2018.07.006

This list was generated on Sat Nov 23 08:29:57 2024 CET.
Provide Feedback